Erasca (ERAS) Interest Coverage Ratio (2020 - 2026)

Erasca's (ERAS) quarterly Interest Coverage Ratio came in at 0.28 in Q1 2026, up 98.82% YoY from 0.14 in Q1 2025, and up 98.72% on a QoQ basis from 21.74 in Q4 2025.

Erasca (ERAS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends

Erasca (ERAS) has 7 years of Interest Coverage Ratio data on file, last reported at 0.28 in Q1 2026.

  • Quarterly Interest Coverage Ratio rose 98.82% year-over-year to 0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.44 (down 100.16% YoY) and the FY2025 annual result came in at 0.58, up 95.79% from the prior year.
  • Interest Coverage Ratio climbed to 0.28 in Q1 2026, from 21.74 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 7.58 in Q4 2023 to a low of 224.52 in Q4 2022.
  • A 5-year average of 17.9 and a median of 2.09 in 2025 frame the typical range for Interest Coverage Ratio.
  • The widest YoY moves for Interest Coverage Ratio: up 103.37% in 2023, down 678.69% in 2023.
  • Tracing ERAS's Interest Coverage Ratio over 5 years: stood at 224.52 in 2022, then soared by 103.37% to 7.58 in 2023, then slumped by 377.29% to 21.01 in 2024, then decreased by 3.47% to 21.74 in 2025, then surged by 98.72% to 0.28 in 2026.
  • The last three Interest Coverage Ratio figures came in at 0.28 (Q1 2026), 21.74 (Q4 2025), and 2.09 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 2.84
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 24.64
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -0.19
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 8.18
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -0.01
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.61
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2.82
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.08
10 Erasca 6.43 Bn 6.16 Bn - -0.06

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.06
Mar 31, 2026 -0.28
Dec 31, 2025 -21.74
Sep 30, 2025 -2.09
Jun 30, 2025 -2.16
Mar 31, 2025 -23.75
Dec 31, 2024 -21.01
Sep 30, 2024 -2.24
Jun 30, 2024 -0.89
Mar 31, 2024 -5.16
Dec 31, 2023 7.58
Sep 30, 2023 -1.34
Jun 30, 2023 -0.42
Mar 31, 2023 -4.23
Dec 31, 2022 -224.52
Sep 30, 2022 -0.42
Jun 30, 2022 -1.17
Mar 31, 2022 -0.54
Dec 31, 2021 -34.12
Sep 30, 2021 -0.19